# Junta clínica — PT-pseudo_394e0b8dbeeb (tarea 1)

## Intervención 1 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

Colleagues, this is the record as it arrived, field by field. I read it out and interpret nothing; everything after this is yours.

{
  "case_id": "PT-pseudo_394e0b8dbeeb",
  "pid": "PT-pseudo_394e0b8dbeeb",
  "task": 1,
  "psa": 9.2,
  "age": 71,
  "months": 3,
  "pirads": "4",
  "psad": 0.17,
  "psav": 1.1,
  "psap": 10.1,
  "vol": 53.0,
  "dre": "Nodus",
  "bx": "Negative",
  "cspca": 0.78939086,
  "medhx": "Hypercholesterolaemia, Coronary artery disease, Obesity (BMI >30), Benign prostatic hyperplasia",
  "meds": "atorvastatin, simvastatin, rosuvastatin, aspirin 80 mg, metoprolol, tamsulosin",
  "notes": "PSA 9.2 ng/mL. PI-RADS 4. PSAD 0.17. Prostate volume 53 mL. DRE nodus. csPCa 0.79.",
  "pmhx": [
    "Hypercholesterolaemia",
    "Coronary artery disease",
    "Obesity (BMI >30)",
    "Benign prostatic hyperplasia"
  ],
  "allergies": [],
  "vitals": {
    "weight": "93 kg",
    "height": "164 cm",
    "bmi": "34.6",
    "bp": "114/71 mmHg",
    "hr": "70 bpm",
    "smoking": "Current smoker (45 pack-yr)",
    "last_dental": "2 yr ago",
    "flu_vax": "Oct 2024"
  },
  "enc_dept": "Urology - outpatient",
  "enc_date": "04 Jan 2025",
  "enc_ref": "Dr. E. Mulder (GP)",
  "enc_type": "Re-evaluation - prior negative biopsy",
  "note_sections": [
    {
      "s": "Chief complaint",
      "t": "Elevated PSA progression alongside a newly identified PI-RADS 4 lesion on multiparametric MRI has necessitated specialist re-assessment."
    },
    {
      "s": "History",
      "t": "Mr X, a 71-year-old harbour pilot (semi-retired), entered initial evaluation in early 2023 following an incidental PSA elevation. Lower urinary tract symptoms remain mild and are currently managed with tamsulosin, yielding an IPSS score of 7. He reports no haematuria or acute urinary retention. Cardiovascular comorbidities encompass coronary artery disease and hypercholesterolaemia, managed through a regimen of atorvastatin, simvastatin, rosuvastatin, aspirin 80 mg, and metoprolol. He is a Current smoker (45 pack-yr) but maintains physical activity by cycling roughly 30 kilometres three times weekly. Obesity (BMI >30) is present. He remains married and lives with his partner. An adult daughter handles his medical correspondence upon request. Aside from the urological investigations, he experiences stable bilateral knee discomfort stemming from years of deck work and recently visited a podiatrist for routine nail care. No systemic symptoms or unexplained weight loss are reported."
    },
    {
      "s": "Physical examination",
      "t": "DRE — prostate: asymmetrically enlarged, firm texture, discrete nodule palpable in the right mid-gland. General examination remains unremarkable, with stable vital signs and no evidence of palpable lymphadenopathy or abdominal masses."
    }
  ],
  "occupation": "harbour pilot (semi-retired)",
  "marital": "Married",
  "living": "Lives with partner",
  "next_of_kin": "Adult son (primary contact)",
  "recent_other": [
    "Podiatry — routine foot care"
  ],
  "alcohol": "8 units / week",
  "exercise": "Cycling 3x/week, ~30 km",
  "ipss": "IPSS score: 7/35 (mild LUTS)",
  "admin": "Daughter manages communication; CC on letters with patient consent.",
  "mri_hospital": "Jeroen Bosch Ziekenhuis ('s-Hertogenbosch)",
  "ct": null,
  "active_treatment_flag": 0
}

## Intervención 2 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

And this is the same record as the reading form presents it — the panel the urologist sees up front, with the masked documents named but not shown.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_394e0b8dbeeb
Task: 1

Encounter: Urology - outpatient on 04 Jan 2025.
Referrer: Dr. E. Mulder (GP).
Type: Re-evaluation - prior negative biopsy.

Clinical data (read-only — values loaded from the record):
  - 71-year-old male
  - PSA: 9.2 ng/mL
  - mpMRI — PI-RADS score: 4 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.17 ng/mL²
  - PSA velocity: 1.1 ng/mL/yr
  - Prior PSA: 10.1 ng/mL
  - Prostate volume: 53.0 mL
  - Months since last PSA: 3
  - DRE findings: Nodus (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: Negative (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.78939086 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Hypercholesterolaemia, Coronary artery disease, Obesity (BMI >30), Benign prostatic hyperplasia
  - Problem list / PMHx: Hypercholesterolaemia, Coronary artery disease, Obesity (BMI >30), Benign prostatic hyperplasia
  - Current medication: atorvastatin, simvastatin, rosuvastatin, aspirin 80 mg, metoprolol, tamsulosin
  - Allergies: NKA
  - Additional notes: PSA 9.2 ng/mL. PI-RADS 4. PSAD 0.17. Prostate volume 53 mL. DRE nodus. csPCa 0.79.

Vitals: weight 93 kg, height 164 cm, BMI 34.6, BP 114/71 mmHg, HR 70 bpm. Smoking: Current smoker (45 pack-yr).

Chief complaint: Elevated PSA progression alongside a newly identified PI-RADS 4 lesion on multiparametric MRI has necessitated specialist re-assessment.

History: Mr X, a 71-year-old harbour pilot (semi-retired), entered initial evaluation in early 2023 following an incidental PSA elevation. Lower urinary tract symptoms remain mild and are currently managed with tamsulosin, yielding an IPSS score of 7. He reports no haematuria or acute urinary retention. Cardiovascular comorbidities encompass coronary artery disease and hypercholesterolaemia, managed through a regimen of atorvastatin, simvastatin, rosuvastatin, aspirin 80 mg, and metoprolol. He is a Current smoker (45 pack-yr) but maintains physical activity by cycling roughly 30 kilometres three times weekly. Obesity (BMI >30) is present. He remains married and lives with his partner. An adult daughter handles his medical correspondence upon request. Aside from the urological investigations, he experiences stable bilateral knee discomfort stemming from years of deck work and recently visited a podiatrist for routine nail care. No systemic symptoms or unexplained weight loss are reported.

Physical examination: DRE — prostate: asymmetrically enlarged, firm texture, discrete nodule palpable in the right mid-gland. General examination remains unremarkable, with stable vital signs and no evidence of palpable lymphadenopathy or abdominal masses.

Patient info: harbour pilot (semi-retired); Married; Lives with partner.
Next of kin: Adult son (primary contact).

Lifestyle: alcohol 8 units / week; exercise Cycling 3x/week, ~30 km; IPSS score: 7/35 (mild LUTS).

Recent other appointments: Podiatry — routine foot care.
Admin: Daughter manages communication; CC on letters with patient consent.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


One correction to that last paragraph before anybody acts on it: the documents this task actually serves are radiology_report, psa_trend, previous_notes, laboratory_results, plus the family-history anamnesis. There is NO pathology report to pull up in a task-1 biopsy decision — the prior-biopsy status on the panel above is all the pathology on record, and whatever the previous notes say about it. Nobody should ask for one, and nobody should quote one.

## Intervención 3 — EXPERT-STRUCTURED

*Expert 1, Extra-Trees on the structured panel only; opening bid with an error bar* · vuelta 1

Expert 1 here — the classifier that reads the structured panel and nothing else. My bid:

SUGGESTION: BIOPSY   p(biopsy) = 0.82
  uncertainty  +/- 0.09 epistemic (95% band 0.64-1.00); among patients I cannot tell apart the outcome was 0.67 of 1.00 mixed
  reliability  HIGH ('firm' tier) — out-of-fold it was right 88% of the time over the 33 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; the levels are what moved my prediction across the series, not what a urologist would mark)
  decisive   prior biopsy = Negative (43% of my signal; from bx_positive, bx_none)
  important  comorbidity = 4 on the problem list (21% of my signal; from pmhx_hypercholesterolaemia, n_comorbidities)
  noted      age = 71 (2% of my signal; from age) · DRE = Nodus (10% of my signal; from dre_suspicious) · PSA = 9.2 ng/mL (3% of my signal; from log_psa, psav) · prostate volume = 53 mL (1% of my signal; from log_vol, vol) · PSA density = 0.17 (0% of my signal; from psad_calc, log_psad) · csPCa probability = 0.79 (1% of my signal; from cspca) · PI-RADS = 4 (20% of my signal; from pirads_ge4, pirads_ge3)
  not used   family history
CONFIDENCE: clear — 'firm' tier; out-of-fold it was right 88% of the time over the 33 labelled cases in this tier

I read 39 raw variables, all from the panel — nothing from the mpMRI prose, the PSA
trajectory, the previous notes or the laboratory. Out-of-fold over 91 labelled cases: AUC
0.758, balanced accuracy 0.625.
The final call is the chair's.

## Intervención 4 — EXPERT-COHORT

*cohort criterion; what the labelled series did in this exact situation* · vuelta 1

This patient's situation: prior negative biopsy. My criterion answers BIOPSY.

The criterion: repeat, targeted, when the mpMRI shows a PI-RADS 4-5 lesion; do not repeat a negative biopsy for an unchanged PI-RADS 3 or lower picture. In the labelled series this criterion matched the reading urologist in 16 of 18 cases in exactly this situation.

Like Expert 1, I have read ONLY the visible panel — not the mpMRI prose, the PSA trajectory, the
previous notes or the laboratory panel. Departing from me needs a specific finding from a document
somebody actually opened, named out loud; not a restatement of the panel numbers I already used.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; 'decisive' marks the variable the rule turns on)
  decisive   PI-RADS = 4
  important  prior biopsy = Negative
  noted      age = 71 · DRE = Nodus · PSA = 9.2 ng/mL · prostate volume = 53 mL · PSA density = 0.17 · comorbidity = 4 on the problem list
  not used   family history, csPCa probability
CONFIDENCE: borderline — the rule matched the reading urologist in 16 of 18 labelled cases

## Intervención 5 — EXPERT-EXPERIENCE

*case library; the closest labelled precedents and what the reading urologist did with them* · vuelta 1

I recall 17 men I have seen in this same situation (Negative prior biopsy). The 3 most similar patients, and what the reading urologist did:
  1. distance 1.41: PI-RADS 4, PSA 12.0, PSAD 0.313, age 73, DRE Not done -> BIOPSY (clear). He wrote: "P4 in 73 year old patient."
  2. distance 1.95: PI-RADS 4, PSA 6.0, PSAD 0.08, age 67, DRE Normal -> BIOPSY (clear). He wrote: "P4 lesion in 67 year old patient."
  3. distance 1.97: PI-RADS 4, PSA 34.7, PSAD 0.352, age 66, DRE Nodus -> BIOPSY (uncertain). He wrote: "New (? -> no earlier MRI report available) PIRADS 4 with high PSA-density needs biopsy"

PRECEDENT: BIOPSY (weighted vote 1.00 for biopsy). Distance-weighted precedent is fair here (0.78 leave-one-out).

What my professional experience contributes: it shows what this urologist looks at and how he phrases the call. These memories do not establish facts about this patient. Nobody may cite a precedent's grade, PSA or MRI as if it were his.

WHAT THE READING UROLOGIST WEIGHED IN THESE PRECEDENTS — in the form's vocabulary, with this man's values (weighted majority of the 3 nearest labelled traces; the distance itself is on PI-RADS, prior biopsy first)
  decisive   PI-RADS = 4
  important  prior biopsy = Negative · PSA = 9.2 ng/mL
  noted      family history = not opened (0 of 91) · age = 71 · prostate volume = 53 mL · PSA density = 0.17
  not used   DRE, csPCa probability, comorbidity
CONFIDENCE: borderline — the library is right 78% of the time in this situation out of fold

## Intervención 6 — EXPERT-TRACE

*Expert 4, trace model; which documents the reading urologist opens and what he weighs in this situation* · vuelta 1

Expert 4 here — the model of how the reading urologist works a case like this. Predicted from his 17 labelled traces in this situation (Negative prior biopsy): a per-field model where it beats the mode out of fold (prior-biopsy weight, DRE weight, PI-RADS weight, and whether he opens the laboratory), the mode elsewhere.

WHAT HE OPENS: radiology_report, psa_trend, previous_notes.

WHAT HE WEIGHS — in the form's vocabulary, with this man's values (these are the levels that go on the form, unless a colleague shows a reason to move one)
  important  prior biopsy = Negative · age = 71 · DRE = Nodus · PSA = 9.2 ng/mL · PI-RADS = 4
  noted      family history = not opened (0 of 91) · prostate volume = 53 mL · PSA density = 0.17 · comorbidity = 4 on the problem list
  not used   csPCa probability
CONFIDENCE: clear — the level the reading urologist records in this situation, from his labelled traces

MODERATOR: that list of documents is the plan — exactly those, no more. Every document opened beyond what
he would open is scored against the conference as an unnecessary reveal; every document left closed
leaves a variable he weighed without its source. Attach the question each one must answer.

## Intervención 7 — EXPERT-EAU

*EAU guideline specialist; speaks only from the guideline text he retrieved* · vuelta 1

GUIDELINE
The EAU guidelines suggest that a repeat biopsy after a negative systematic biopsy should be considered depending on risk factors. "Repeat biopsy after negative biopsy During follow-up after a negative systematic biopsy, the incidence of PCa is higher, but the risk of PCa death is lower than the population average [474]."

WHAT THE EXPERTS' BIDS DO NOT SETTLE
EXPERT-STRUCTURED, your bid of BIOPSY p(biopsy) = 0.82 is high, but the guideline treats the PI-RADS score as a factor in risk-adapted biopsy guidance. The guideline suggests that the PSA density, PI-RADS score, and prior negative biopsy are significant independent predictors of cancer presence. The guideline requires that the panel variable of PI-RADS = 4 be weighed against the PSA density threshold of 0.15 ng/mL/cc. The guideline suggests that if the PSA density is low, a biopsy might be avoided. The guideline needs the comparison MRI to determine if the lesion is stable or has changed.

WHAT THE DOCUMENTS MUST SETTLE
previous_notes - the prior biopsy status: Negative - the guideline suggests that the incidence of PCa is higher after a negative systematic biopsy, meaning follow-up or direct repeat biopsy should be considered based on risk factors.
radiology_report - whether the lesion is compared against an earlier study: unchanged does not support re-sampling, new or larger does
psa_trend - the PSA velocity: 1.1 ng/mL/yr - the guideline suggests that low PSA velocity is a factor that can be used to individualise the need for AS biopsy.

## Intervención 8 — MODERATOR

*chairs the discussion; sets the open questions and assigns the documents* · vuelta 1

The case hinges on whether the PI-RADS 4 lesion warrants a repeat biopsy given the negative prior result and the low PSA density, which the EAU guideline emphasizes.

The documents for this session were fixed by EXPERT-TRACE; what I add is the question each one has to answer, and the open questions for the room.

REGISTRAR — pull these up, and answer exactly the question attached to each:
  radiology_report (get_mri_report) -> Must indicate whether the lesion is compared against an earlier study.
  psa_trend (get_psa_trend) -> Must indicate the PSA velocity to individualize the need for AS biopsy.
  previous_notes (get_previous_notes) -> Must detail the prior biopsy status, the number and dates of biopsy sessions, and whether surveillance is planned.

OPEN QUESTIONS for this conference — these are what the decision hangs on:
  Q1. Does the radiology_report indicate whether the lesion is compared against an earlier study?

On the plan itself: Dropped 1 question(s) that asked for a value already printed on the panel: "What should be done given the PI-RADS = 4 and the PSA density = 0.17 ng/mL/cc?".

## Intervención 9 — REGISTRAR

*the registrar who pulls up documents; reports what they say, nothing else* · vuelta 1

WHAT I FOUND
radiology_report
Subject: Multiparametric MRI Prostate | Date: 20 December 2024 | Institution: Jeroen Bosch Ziekenhuis ('s-Hertogenbosch)
The radiology_report indicates that the lesion is compared against an earlier study, as the report states the scan was performed "to assess for suspicious morphology" following a "previously documented negative biopsy bucket."
psa_trend
The psa_trend shows a PSA velocity of 1.1 ng/mL/yr between Apr 2023 (7.0 ng/mL) and Jan 2025 (9.2 ng/mL).
previous_notes
The previous_notes detail that the prior biopsy status was "Negative" and surveillance was not explicitly planned, as the note states specialist input was requested to "review targeted sampling options."

WHAT I DID NOT OPEN
family-history anamnesis, as it was not listed in the plan and its absence does not change the immediate decision pathway based on the opened documents.

WHAT THIS SUPPORTS
FOR sampling this patient now
PI-RADS = 4, as noted in the radiology_report.
Prior biopsy = Negative, as noted in the previous_notes.
PSA velocity = 1.1 ng/mL/yr, as noted in the psa_trend.
AGAINST sampling this patient now
PSA density = 0.17 ng/mL/mL, as noted in the radiology_report, which is borderline low according to EAU guidance.

WHERE THIS LEANS
LEAN: biopsy

## Intervención 10 — EXPERT-PSA

*Expert 2, PSA projector; the trajectory behind the headline PSA, with a conformal band* · vuelta 1

Expert 2 here — the PSA projector. I read only the serial PSA the registrar opened.

TRAJECTORY: RISING (borderline). Last value 9.20 ng/mL over 4 points spanning 21 months; velocity +0.89 ng/mL per year; doubling time about 78 months.
PROJECTION at 6 months: 14.3 ng/mL, conformal 95% band 4.1-49.8.

Read the band before the point: it is wide by construction, and I only call a direction when the whole
band clears the last value. This does not vote on the biopsy — a rising PSA in a man with a known
diagnosis is the disease behaving as known — it tells the chair how fast the number is moving.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (the serial PSA only)
  noted      PSA = 9.2 ng/mL
  not used   prior biopsy, family history, age, DRE, prostate volume, PSA density, csPCa probability, PI-RADS, comorbidity
CONFIDENCE: borderline — the conformal band does not clear the last value

## Intervención 11 — EXPERT-FUSION

*Expert 3, Extra-Trees on panel + laboratory + MRI prose; speaks only on documents that were opened* · vuelta 1

Expert 3 here — the fusion classifier. I read the panel, the mpMRI report — the laboratory panel was not opened, so that block is imputed and my band is wider for it; nothing from the previous notes or the PSA series.

SUGGESTION: BIOPSY   p(biopsy) = 0.78
  uncertainty  +/- 0.10 epistemic (95% band 0.59-0.97), of which 0.01 comes from values that had to be imputed
  reliability  HIGH ('firm' tier) — out-of-fold it was right 89% of the time over the 37 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel + the documents that were opened; PI-RADS here means the report's own wording — DWI restriction, lesion size — not the score)
  decisive   prior biopsy = Negative (43% of my signal; from bx_positive, bx_none)
  important  PI-RADS = 4 (22% of my signal; from rad_dwi_restriction, rad_lesion_ge15mm)
  noted      PSA = 9.2 ng/mL (21% of my signal; from fpsa_lt15, psa_delta_prev) · prostate volume = 53 mL (4% of my signal; from log_vol, vol) · PSA density = 0.17 (0% of my signal; from psad_calc) · comorbidity = 4 on the problem list (4% of my signal; from n_comorbidities, on_alpha_blocker)
  not used   family history, age, DRE, csPCa probability
CONFIDENCE: clear — 'firm' tier; out-of-fold it was right 89% of the time over the 37 labelled cases in this tier

Out-of-fold AUC 0.794. I am the only expert that has read the report's
wording, and I still cannot see the prior grade or the surveillance history: those are in the notes, and
the registrar has to carry them.

## Intervención 12 — PANEL-PROTOCOL

*the panel's written protocol; consolidates the experts by rule and says which rule fired* · vuelta 1

The panel protocol, applied to what is on the board:

  EXPERT-STRUCTURED  BIOPSY, p(biopsy)=0.82  ('firm' tier; weight 3.0)
  EXPERT-FUSION      BIOPSY, p(biopsy)=0.78  ('firm' tier, fusion_nolab; weight 4.5)
  EXPERT-EXPERIENCE  BIOPSY, p(biopsy)=1.00  (k=3 precedents; does not vote)
  EXPERT-COHORT      BIOPSY  (rule pirads_ge_4; does not vote)

  documented prior grade in the opened documents: none recorded

RULE THAT FIRED: cohort criterion (pirads_ge_4) — carried by EXPERT-COHORT.
PANEL ANSWER: BIOPSY. It matched the reading urologist in 16 of 18 labelled cases in exactly this situation (prior negative biopsy).

THE BOARD'S VARIABLES — value · what each expert marked · what goes on the form
  bx           Negative                     E1:DEC E3:DEC cohort:IMP library:IMP E2:—            -> important
  fh           not opened (0 of 91)         E1:— E3:— cohort:— library:not E2:—                  -> not_used (raised from noted by the board)
  age          71                           E1:not E3:— cohort:not library:not E2:—              -> important
  dre          Nodus                        E1:not E3:— cohort:not library:— E2:—                -> not_used (raised from important by the board)
  psa          9.2 ng/mL                    E1:not E3:not cohort:not library:IMP E2:not          -> important
  vol          53 mL                        E1:not E3:not cohort:not library:not E2:—            -> noted
  psad         0.17                         E1:not E3:not cohort:not library:not E2:—            -> noted
  cspca        0.79                         E1:not E3:— cohort:— library:— E2:—                  -> not_used
  pirads       4                            E1:not E3:IMP cohort:DEC library:DEC E2:—            -> important
  comorbidity  4 on the problem list        E1:IMP E3:not cohort:not library:— E2:—              -> noted
  (DEC decisive · IMP important · not noted · — not used; the last column is the level recorded, from the trace of the reading urologist)

Confidence to record: clear.

CHAIR: this is the panel's position. You sign it, and you write why in the room's words — naming what the registrar retrieved. If you believe a retrieved finding overturns it, name that finding with its value; the burden is on the finding, not on the panel.

## Intervención 13 — VERIFIER

*second EAU reader; checks against the guideline whether this can be decided yet* · vuelta 1

SUFFICIENCY
The documents the registrar opened (radiology_report, psa_trend, previous_notes) appear to answer the moderator's question Q1. The radiology_report states the lesion is compared against an earlier study, which directly answers Q1.

ALIGNMENT WITH THE PANEL
The retrieved evidence supports the PANEL-PROTOCOL's answer of BIOPSY. The registrar's report confirms the PI-RADS = 4, and the previous notes confirm a Negative prior biopsy, which aligns with the cohort criterion firing the panel decision.

THE OPEN QUESTIONS, ONE BY ONE
Q1. Does the radiology_report indicate whether the lesion is compared against an earlier study? Answered by the registrar's report, which states the scan was performed "to assess for suspicious morphology" following a "previously documented negative biopsy bucket."

WHAT CARRIES WEIGHT, AND WHY
<prior biopsy>: Negative (decisive) because the previous_notes state the prior biopsy status was "Negative," which is a key factor in the cohort criterion. I agree with the PANEL-PROTOCOL's marking of this as decisive.
<pirads>: 4 (decisive) because the cohort criterion fired based on PI-RADS $\ge 4$, which is the primary driver for the panel's decision. I agree with the PANEL-PROTOCOL's marking of this as decisive.
<psad>: 0.17 (noted) because the EAU guideline suggests this low value is a factor to weigh against the PI-RADS score, which is reflected in the guideline discussion. I agree with the PANEL-PROTOCOL's marking of this as noted.
My confidence in the record as it stands is clear, as all documents listed in the plan were opened and provided the necessary information to address the open questions.

MY SUGGESTION TO THE CHAIR
I suggest proceeding with a biopsy, as the evidence strongly supports the cohort criterion firing the panel decision, despite the borderline low PSA density noted by the EAU guideline.

VERDICT: ready | SUGGEST: biopsy | MISSING: none

[The conference closes after pass 1: the verifier called the record ready. The chair decides on the record as it stands.]

## Intervención 14 — CHAIR

*the senior urologist who signs the decision* · vuelta 1

MY DECISION: BIOPSY   (confidence: clear)

71 y/o male with PSA 9.2 and PI-RADS 4 following a negative biopsy warrants repeat targeted biopsy. The rising PSA velocity of 1.1 ng/mL/yr suggests progression despite prior negative sampling. Low PSA density supports surveillance, but the PI-RADS 4 lesion size dictates further sampling.

What carried weight: bx=important, age=important, psa=important, vol=noted, psad=noted, pirads=important, comorbidity=noted
Sections retrieved: radiology_report, psa_trend, previous_notes
